Quantcast
Last updated on April 16, 2014 at 21:24 EDT

Latest Singapore Immunology Network Stories

2014-02-13 00:20:12

The collaboration with Sanofi Pasteur aims to study the loss of immunity and consequent reduced responsiveness to vaccination in elderly.Singapore, Feb 13, 2014 - (ACN Newswire) - A*STAR's Singapore Immunology Network (SIgN) signed a three-year partnership with the National University of Singapore (NUS), National University Hospital (NUH) and Sanofi Pasteur to embark on a Phase IV clinical trial to understand age-related loss of immunity, known as immunosenescence, in elderly.Declining birth...

2013-12-02 00:20:07

First EMBO workshop in Singapore marks new milestone in Singapore-Europe cooperation in life sciencesSingapore, Dec 2, 2013 - (ACN Newswire) - A*STAR's Singapore Immunology Network (SIgN) will host Singapore's inaugural European Molecular Biology Organisation (EMBO) workshop on Complex Systems in Immunology from 2nd to 4th December 2013. The 3-day event will bring together researchers from Europe and Singapore to discuss and share the latest insights in...

2013-11-14 12:54:05

New knowledge of drug mechanism paves road to new treatment approaches for patients suffering from frequent bacterial infections 1. Scientists at A*STAR’s Singapore Immunology Network (SIgN) have discovered the exact mode of action by plerixafor, a drug commonly prescribed to stimulate immune responses in patients suffering from neutropenia, which causes them to become prone to oral, skin, genital infections and in worst cases, a fatal whole-body infection.  A better understanding of...

2013-11-14 00:20:06

New knowledge of drug mechanism paves road to new treatment approaches for patients suffering from frequent bacterial infectionsSingapore, Nov 14, 2013 - (ACN Newswire) - Scientists at A*STAR's Singapore Immunology Network (SIgN) have discovered the exact mode of action by plerixafor, a drug commonly prescribed to stimulate immune responses in patients suffering from neutropenia, which causes them to become prone to oral, skin, genital infections and in worst cases, a...

2013-09-10 08:20:02

A*STAR scientists' discovery opens doors to developing new therapies to eradicate tumour cells and combat infectionsSingapore, Sept 10, 2013 - (ACN Newswire) - Scientists from A*STAR's Singapore Immunology Network (SIgN) have discovered a new defense mechanism that the immune system utilises to combat infections. The team's discovery of how a novel protein unexpectedly activates an immune response shows how this mechanism can also be used to get rid of tumour cells....

2013-08-13 11:16:11

A new strategy that cripples the ability of the dengue virus to escape the host immune system has been discovered by A*STAR’s Singapore Immunology Network (SIgN). This breakthrough strategy opens a door of hope to what may become the world’s first universal dengue vaccine candidate that can give full protection from all four serotypes of the dreadful virus. This research done in collaboration with Singapore’s Novartis Institute of Tropical Diseases (NITD) and Beijing Institute of...

2013-08-13 00:20:06

Singapore, Aug 13, 2013 - (ACN Newswire) - A new strategy that cripples the ability of the dengue virus to escape the host immune system has been discovered by A*STAR's Singapore Immunology Network (SIgN). This breakthrough strategy opens a door of hope to what may become the world's first universal dengue vaccine candidate that can give full protection from all four serotypes of the dreadful virus. This research done in collaboration with Singapore's Novartis Institute of Tropical Diseases...

2013-07-17 11:07:59

1. Scientists at A*STAR’s Singapore Immunology Network (SIgN) have discovered a new class of white blood cells in human lung and gut tissues that play a critical role as the first line of defense against harmful fungal and bacterial infections. This research will have significant impact on the design of vaccines and targeted immunotherapies for diseases caused by infectious microbes such as the hospital-acquired pneumonia. 2. The scientists also showed for the first time...

2012-07-19 08:20:01

Singapore, July 19, 2012 - (ACN Newswire) - Professor Paola Castagnoli, Scientific Director of A*STAR's Singapore Immunology Network (SIgN) has been conferred the honour of the "Order of the Star of Italy" (Ufficiale dell'Ordine della Stella d'Italia). This is one of the highest civil honoursawarded by the President of the Italian Republic to Italians overseas and foreigners who have made outstanding contributions to the preservation and promotion of Italy's national prestige abroad. For her...

2012-07-16 11:14:56

1. Scientists at A*STAR´s Singapore Immunology Network (SIgN), in collaboration with Newcastle University, UK, the Singapore Institute of Clinical Sciences and clinicians from multiple hospitals in Singapore, have identified a new subset of dendritic cells (DCs) in human peripheral tissue which have a critical role in activating our immune response against harmful pathogens. This research will have significant impact on the design of vaccines and other targeted immunotherapies. The...